5NUK
Engineered beta-lactoglobulin: variant I56F-L39A-M107F in complex with chlorpromazine (LG-FAF-CLP)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SEALED TUBE |
Source details | OXFORD DIFFRACTION NOVA |
Temperature [K] | 120 |
Detector technology | CCD |
Collection date | 2016-04-05 |
Detector | AGILENT ATLAS CCD |
Wavelength(s) | 1.54 |
Spacegroup name | P 32 2 1 |
Unit cell lengths | 53.160, 53.160, 112.619 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 14.810 - 1.700 |
R-factor | 0.22007 |
Rwork | 0.215 |
R-free | 0.26864 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1bsy |
RMSD bond length | 0.010 |
RMSD bond angle | 1.441 |
Data reduction software | CrysalisPro |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0073) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 14.810 | 1.730 |
High resolution limit [Å] | 1.700 | 1.700 |
Rmerge | 0.036 | 0.495 |
Number of reflections | 20925 | 1116 |
<I/σ(I)> | 10.5 | 1.4 |
Completeness [%] | 99.8 | 99.4 |
Redundancy | 2.7 | 2.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8 | 293 | 2.80 M (NH4)2SO4, 0.1 M Tris pH 8.0 |